Revision as of 21:34, 8 August 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI').← Previous edit | Latest revision as of 22:11, 10 January 2025 edit undoArthurfragoso (talk | contribs)Extended confirmed users, Template editors4,591 edits dark mode fix | ||
(38 intermediate revisions by 27 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Topical NSAID medication}} | |||
{{drugbox | |||
{{Drugbox | |||
| Verifiedfields = changed | |||
| |
| Watchedfields = changed | ||
⚫ | | verifiedrevid = 443752362 | ||
⚫ | | UNII = 94WNJ5U8L7 | ||
⚫ | | IUPAC_name = biphenyl-4-ylacetic acid | ||
⚫ | | verifiedrevid = |
||
⚫ | | image = Felbinac.svg | ||
⚫ | | IUPAC_name |
||
| image_class = skin-invert-image | |||
⚫ | | image |
||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|felbinac}} | |||
⚫ | | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | ||
⚫ | | pregnancy_US = <!-- A / B / C / D / X --> | ||
⚫ | | pregnancy_category = | ||
⚫ | | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | ||
⚫ | | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | ||
⚫ | | legal_UK = P | ||
⚫ | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
⚫ | | legal_status = | ||
⚫ | | routes_of_administration = Topical | ||
<!--Pharmacokinetic data--> | |||
⚫ | | bioavailability = | ||
⚫ | | protein_bound = | ||
⚫ | | metabolism = | ||
⚫ | | elimination_half-life = | ||
⚫ | | excretion = | ||
<!--Identifiers--> | |||
⚫ | | CAS_number = 5728-52-9 | ||
⚫ | | ATC_prefix = M02 | ||
⚫ | | ATC_suffix = AA08 | ||
⚫ | | PubChem = 3332 | ||
⚫ | | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
⚫ | | DrugBank = DB07477 | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| ChemSpiderID = 3215 | | ChemSpiderID = 3215 | ||
⚫ | | UNII_Ref = {{fdacite|correct|FDA}} | ||
| InChI = 1/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) | |||
⚫ | | UNII = 94WNJ5U8L7 | ||
| InChIKey = QRZAKQDHEVVFRX-UHFFFAOYAC | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
⚫ | | smiles = O=C(O)Cc1ccc(cc1)c2ccccc2 | ||
⚫ | | KEGG = D01675 | ||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
⚫ | | ChEBI = 31597 | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | | ChEMBL_Ref = {{ebicite|correct|EBI}} | ||
| ChEMBL = 413965 | | ChEMBL = 413965 | ||
<!--Chemical data--> | |||
⚫ | | C=14 | H=12 | O=2 | ||
⚫ | | smiles = O=C(O)Cc1ccc(cc1)c2ccccc2 | ||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChI = 1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) | | StdInChI = 1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) | ||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChIKey = QRZAKQDHEVVFRX-UHFFFAOYSA-N | | StdInChIKey = QRZAKQDHEVVFRX-UHFFFAOYSA-N | ||
⚫ | | CAS_number |
||
⚫ | | ATC_prefix |
||
⚫ | | ATC_suffix |
||
⚫ | | ChEBI = 31597 | ||
⚫ | | PubChem |
||
⚫ | | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
⚫ | | DrugBank = DB07477 | ||
⚫ | | |
||
⚫ | | KEGG = D01675 | ||
⚫ | | C=14|H=12|O=2 | ||
| molecular_weight = 212.244 g/mol | |||
⚫ | | bioavailability |
||
⚫ | | protein_bound |
||
⚫ | | metabolism |
||
⚫ | | elimination_half-life = | ||
⚫ | | excretion |
||
⚫ | | pregnancy_AU |
||
⚫ | | pregnancy_US |
||
⚫ | | pregnancy_category= | ||
⚫ | | legal_AU |
||
⚫ | | legal_CA |
||
⚫ | | legal_UK |
||
⚫ | | legal_US |
||
⚫ | | legal_status |
||
⚫ | | routes_of_administration = Topical | ||
}} | }} | ||
⚫ | '''Felbinac''' (] |
||
⚫ | '''Felbinac''' (], or '''biphenylylacetic acid''') is a ] medicine,<ref>''The Merck Index'', 12th Edition. 3989</ref> belonging to the family of medicines known as ]s (NSAIDs) of the arylacetic acid (not arylpropionic acid) class, which is used to treat muscle inflammation and ].<ref>Description of Felbinac on Tiscali </ref> It is an active metabolite of ].<ref name="KTWE1980">{{cite journal |vauthors=Kohler C, Tolman E, Wooding W, Ellenbogen L | title=A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function | journal=Arzneimittelforschung | volume=30 | issue=4A | pages=702–707 | year=1980 | pmid=6254545}}</ref> | ||
== Footnotes == | |||
⚫ | {{Reflist}} | ||
== |
==Related compounds== | ||
The α-methyl acid of felbinac is called ] and is used to prepare ]. The α-ethyl acid is called ] which is used to make ]. | |||
{{refbegin}} | |||
* The Merck Index, 12th Edition. 3989 | |||
* Description of Felbinac on Tiscali | |||
{{refend}} | |||
==See also== | |||
{{med-stub}} | |||
*] | |||
== References == | |||
⚫ | {{Reflist}} | ||
{{NSAIDs}} | {{NSAIDs}} | ||
{{Topical products for joint and muscular pain}} | {{Topical products for joint and muscular pain}} | ||
{{Prostanoidergics}} | |||
⚫ | ] | ||
⚫ | ] | ||
{{musculoskeletal-drug-stub}} | |||
] |
Latest revision as of 22:11, 10 January 2025
Topical NSAID medication Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.024.758 |
Chemical and physical data | |
Formula | C14H12O2 |
Molar mass | 212.248 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Felbinac (INN, or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs) of the arylacetic acid (not arylpropionic acid) class, which is used to treat muscle inflammation and arthritis. It is an active metabolite of fenbufen.
Related compounds
The α-methyl acid of felbinac is called biprofen and is used to prepare bifepramide. The α-ethyl acid is called xenbucin which is used to make xenthiorate.
See also
References
- The Merck Index, 12th Edition. 3989
- Description of Felbinac on Tiscali
- Kohler C, Tolman E, Wooding W, Ellenbogen L (1980). "A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function". Arzneimittelforschung. 30 (4A): 702–707. PMID 6254545.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
Topical products for joint and muscular pain (M02) | |||||||
---|---|---|---|---|---|---|---|
Anti-inflammatory preparations, non-steroids |
| ||||||
Capsaicin derivatives | |||||||
Other |
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |